Close Menu

NEW YORK – Providers of cell-free DNA-based noninvasive prenatal testing (NIPT) have been differentiating their offerings by adding new conditions or improving the performance of their tests. LabCorp's Integrated Genetics, for example, recently demonstrated that its MaterniT21 Plus test, originally developed by Sequenom, has become more reliable for multifetal pregnancies over time, including triplet pregnancies.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.